The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics

EK Rowinsky, RC Donehower - Pharmacology & therapeutics, 1991 - Elsevier
Although there has been a rapid expansion of the number of classes of compounds with
antineoplastic activity, few have played a more vital role in the curative and palliative …

[图书][B] Perez & Brady's principles and practice of radiation oncology

EC Halperin, LW Brady, DE Wazer, CA Perez - 2013 - books.google.com
Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic
coverage of topics ranging from basic science to sophisticated computer-based radiation …

Malignant thymoma: current status of classification and multimodality treatment

IGH Schmidt-Wolf, JK Rockstroh, H Schüller… - Annals of …, 2003 - Springer
Classification, understanding of the pathophysiology, and treatment options of thymoma
have changed during recent years. It is hoped that novel strategies will lead to a survival …

Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases

K Ogawa, T Toita, T Uno, N Fuwa, Y Kakinohana… - Cancer, 2002 - Wiley Online Library
BACKGROUND Thymic carcinomas are rare neoplasms, and information regarding the
results of treatment and possible prognostic factors in patients with these tumors is limited …

Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma

P Macchiarini, A Chella, F Ducci, B Rossi, C Testi… - Cancer, 1991 - Wiley Online Library
Abstract Between January 1988 and June 1990, seven previously untreated patients with
histologically confirmed and clinically staged IIIa invasive thymoma (IT) were enrolled in a …

Chemotherapy and operation for invasive thymoma

F Rea, F Sartori, M Loy, F Calabrò, A Fornasiero… - The Journal of thoracic …, 1993 - Elsevier
Sixteen patients with invasive thymoma (stage III and stage IVA) were treated with
chemotherapy and then operation. All tumors were considered nonresectable after first …

Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)

T Koizumi, Y Takabayashi, S Yamagishi… - American journal of …, 2002 - journals.lww.com
The role of systemic chemotherapy and optimal regimen in thymic carcinoma remains
uncertain. We evaluated the clinical responsiveness of ADOC (cisplatin, doxorubicin …

On the histologic heterogeneity of thymic epithelial neoplasms: impact of sampling in subtyping and classification of thymomas

CA Moran, S Suster - American journal of clinical pathology, 2000 - academic.oup.com
Six hundred thirty cases of thymomas were evaluated to determine morphologic
heterogeneity. The thymomas were grouped in 4 categories using previous terminology …

Nonsurgical management of malignant thymoma

M Hejna, I Haberl, M Raderer - … International Journal of the …, 1999 - Wiley Online Library
Nonsurgical management of malignant thymoma - Hejna - 1999 - Cancer - Wiley Online
Library Skip to Article Content Skip to Article Information American Cancer Society Journals …

Thymoma. A retrospective study of 87 cases

HS Park, DM Shin, JS Lee, R Komaki, A Pollack… - Cancer, 1994 - Wiley Online Library
Background. The authors retrospectively analyzed 87 patients with malignant thymoma
treated at MD Anderson Cancer Center between 1951 and 1990. The analysis examined the …